A 12-month prospective, observational study evaluating the impact of disease-modifying treatment on emotional burden in recently-diagnosed multiple sclerosis patients: The POSIDONIA study.
Montanari E, Rottoli M R, Maimone D, Confalonieri P, Plewnia K, Frigo M, Francia A, Pala A, Losignore N A, Ragonese P, et al.
J Neurol Sci. 2016 May 15; 364:105-9. Epub 2016 Feb 20. PMID: 27084226.Abstract